Board Member
CurrentAntidote Therapeutics is a science-driven biopharmaceutical company developing novel nicotine-blocking therapies to treat diseases caused or worsened by nicotine.
Nov 2017 - Present
AeroLeads people directory · profile
Bob Ward Email & Phone Number
Experienced Board Director and Chair
at
Antidote Therapeutics, Inc.
2 work emails found
@npsp.com
3 phones found area 617
LinkedIn matched
✓ Verified August 2026
4 data sources
Profile completeness 100%
Current company
Role
Experienced Board Director and Chair
Location
Philadelphia, Pennsylvania, United States
Who is Bob Ward? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Bob Ward is listed as Experienced Board Director and Chair at Antidote Therapeutics, Inc., based in Philadelphia, Pennsylvania, United States. AeroLeads shows a work email signal at npsp.com, phone signal with area code 617, and a matched LinkedIn profile for Bob Ward.
Bob Ward previously worked as Board Member at Antidote Therapeutics, Inc. and Member of Board of Overseers at New Jersey Institute Of Technology. Bob Ward holds Master'S Degree, Immunology from The Johns Hopkins University School Of Medicine.
Company email context
Email format at Antidote Therapeutics, Inc.
This section adds company-level context without repeating Bob Ward's masked contact details.
{first_initial}{last}@npsp.com
89% confidence
AeroLeads found 2 current-domain work email signals for Bob Ward. Compare company email patterns before reaching out.
Profile bio
About Bob Ward
Experienced CEO in building Biotechnology companies to achieve successful value creation milestones, such as Initial Public Offering (IPO); first FDA approval; first product launch. Grew Radius Health from a small private clinical stage company to #1 performing IPO; approval and launch of TYMLOS; created Oncology pipeline with a diverse and innovative team culture. Brought Eloxx Pharmaceuticals “onshore” building out Boston/PA footprint; listing on NASDAQ; advancing Rare disease portfolio. Experienced Board Director for both US (RDUS, ONCS, ELOX) and European Headquartered Public Companies (AKTX); Served as Chair for both Audit and Governance Board Committees. Currently serving on OncoSec Immunotherapies Board of Directors and on two early stage private Biotechnology Companies.
Listed skills include Biotechnology, Drug Development, Oncology, Pharmaceutical Industry, and 33 others.
Current workplace
Bob Ward's current company
Company context helps verify the profile and gives searchers a useful next step.
7 roles
Bob Ward work experience
A career timeline built from the work history available for this profile.
Member Of Board Of Overseers
The NJIT Board of Overseers serves as the governing body for the Foundation at NJIT, a 501(c ) (3) tax-exempt organization which is the fundraising arm of the university. The Board of Overseers has fiduciary responsibility for the Foundation, provides a leadership role in fundraising, and provides a critical link between academe and the business community, providing information on corporate and state priorities and assisting NJIT in meeting research and funding goals.
Oct 2022 - Oct 2023
Member Of Board Of Directors, Audit Committee Chair
Oncosec Immunotherapies Inc (Oncs)
Independent Board Director (Nonexecutive Director, NED)Scope Includes-Mergers & Acquisitions-Corporate Finance-Business Development-SOX and Risk Management-Corporate Strategy-Strategic Planning-Investor Relations
Nov 2018 - Nov 2021
Member Of Board Of Directors
Public PolicyTechnology Management
Aug 2015 - Sep 2020
Ceo And Chairman Of The Board
Eloxx Pharmaceuticals (Elox)
Uplisted Eloxx to Nasdaq (ELOX) in 2018 - Startup US Operations - Advanced Cystic Fibrosis Program to Phase 2 (Orphan Drug, Pediatric, Personalized Medicine) - Established New Indications in Ophthalmology, Renal Diseases. Developed C-Suite Talent and Promotion of COO to CEO Role. Grew Company from 6 US Employees. Eloxx Pharmaceuticals Announces Uplisting to Nasdaq and Pricing of $50 Million Public Offering of Common Stock-Strategic Planning-Research & Development-Portfolio Planning-Corporate Finance-IPO-Investor Relations-President and CEO-Board of Directors-Chairman of the Board of DirectorsSectors: US | International | Europe | Japan | China | Canada | Latin AmericaProduct Areas: Prescription | Biologics | Endocrinology | Immunology | Women's Health | Oncology | Orphan Drug | Neuroscience | Gene Therapy | Personalized MedicineSpecialties: Executive Leadership | Board Relations | Partner Management | P&L Management | Corporate Strategy | M&A Integration | Business Development | Commercial Assessments | Life Cycle Management | Commercial Operations | Sales and Marketing | New Product Development | Contracting | Pricing and Reimbursement | Managed Care | Government Affairs | Professional Relations | Strategic Planning | Market Research | Talent Development | Innovation
Dec 2017 - Feb 2020
Member Of Board Of Directors, Governance Committee Chair
Akari Therapeutics Plc (Aktx)
Independent Board Director (Nonexecutive Director, NED)Scope Includes-Governance Chair-Board of Directors-Corporate Finance-Strategy-Strategic Planning-Biologics, Personalized Medicine-European, Global
Oct 2016 - Aug 2018
Ceo And Member Of Board Of Directors
Radius Health, Inc. (Rdus)
Listed Radius Health on NASDAQ (RDUS IPO) in 2014 - completed Global Phase III Trial Program in Osteoporosis (Women's Health, Endocrinology) - FDA Approval of TYMLOS™ - Commercial Launch in US - Partnership for Japan - Advanced RAD1901 Breast Cancer Program to Phase 2 (Oncology, Personalized Medicine, Genomic Medicine) - Started with 7 employees grew to over 500Radius: The Top Performing IPO of 2014https://www.mpmcapital.com/press/radius-top-ipo-2014/. FDA Approves Radius Health’s TYMLOS™ (abaloparatide)https://www.nof.org/news/fda-approves-radius-healths-tymlos-abaloparatide/ Here are the 9 fastest-growing biotech firms in the Bay Statehttps://www.bizjournals.com/boston/blog/bioflash/2016/03/here-are-the-9fastest-growing-biotech-firms-in-the.htmlMad MoneyRadius Health CEO Robert Ward: Biotech Bliss | Mad Money | CNBChttps://www.youtube.com/watch?v=f8C_uZiqdmIRadius Health CEO: A Stock Check-Up| Mad Money | CNBChttps://www.youtube.com/watch?v=zWLbZwphWDIRadius Health CEO: Healthy Profits? | Mad Money | CNBChttps://www.youtube.com/watch?v=JlBeEbvwIm8Scope Includes-Product Launch-Commercialization-IPO-Corporate Finance-Research & Development-Board of Directors-President and CEO-Start Up-Mergers & Acquisitions-Business Development-Strategy-Human Resources-Biologics, Proteins, Biosimilars-Intellectual Property
Dec 2013 - Jul 2017
4 education records
Bob Ward education
Master'S Degree, Immunology
The Johns Hopkins University School Of Medicine
Master'S Degree, Business Administration And Management, General
New Jersey Institute Of Technology
Bachelor Of Science - Bs, Physiological Psychology/Psychobiology
Uc Santa Barbara
Bachelor Of Arts - Ba, Biology/Biological Sciences, General
Uc Santa Barbara
FAQ
Frequently asked questions about Bob Ward
Quick answers generated from the profile data available on this page.
What company does Bob Ward work for?
Bob Ward works for Antidote Therapeutics, Inc..
What is Bob Ward's role at Antidote Therapeutics, Inc.?
Bob Ward is listed as Experienced Board Director and Chair at Antidote Therapeutics, Inc..
What is Bob Ward's email address?
AeroLeads has found 2 work email signals at @npsp.com for Bob Ward at Antidote Therapeutics, Inc..
What is Bob Ward's phone number?
AeroLeads has found 3 phone signal(s) with area code 617 for Bob Ward at Antidote Therapeutics, Inc..
Where is Bob Ward based?
Bob Ward is based in Philadelphia, Pennsylvania, United States while working with Antidote Therapeutics, Inc..
What companies has Bob Ward worked for?
Bob Ward has worked for Antidote Therapeutics, Inc., New Jersey Institute Of Technology, Oncosec Immunotherapies Inc (Oncs), Massachusetts High Technology Council, and Eloxx Pharmaceuticals (Elox).
How can I contact Bob Ward?
You can use AeroLeads to view verified contact signals for Bob Ward at Antidote Therapeutics, Inc., including work email, phone, and LinkedIn data when available.
What schools did Bob Ward attend?
Bob Ward holds Master'S Degree, Immunology from The Johns Hopkins University School Of Medicine.
What skills is Bob Ward known for?
Bob Ward is listed with skills including Biotechnology, Drug Development, Oncology, Pharmaceutical Industry, Cross Functional Team Leadership, Strategy, Biopharmaceuticals, and Clinical Development.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial